These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21958736)
1. Identification of new antimalarial leads by use of virtual screening against cytochrome bc₁. Rodrigues T; Moreira R; Gut J; Rosenthal PJ; O Neill PM; Biagini GA; Lopes F; dos Santos DJ; Guedes RC Bioorg Med Chem; 2011 Nov; 19(21):6302-8. PubMed ID: 21958736 [TBL] [Abstract][Full Text] [Related]
2. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex. Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379 [TBL] [Abstract][Full Text] [Related]
3. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304 [TBL] [Abstract][Full Text] [Related]
4. Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design. McKay PB; Peters MB; Carta G; Flood CT; Dempsey E; Bell A; Berry C; Lloyd DG; Fayne D Bioorg Med Chem Lett; 2011 Jun; 21(11):3335-41. PubMed ID: 21531557 [TBL] [Abstract][Full Text] [Related]
5. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy. Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073 [TBL] [Abstract][Full Text] [Related]
17. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase. Wadood A; Ulhaq ZU J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582 [TBL] [Abstract][Full Text] [Related]
18. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition. Adane L; Patel DS; Bharatam PV Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors--a possible new antimalarial target. Aparicio IM; Marín-Menéndez A; Bell A; Engel PC Mol Biochem Parasitol; 2010 Aug; 172(2):152-5. PubMed ID: 20399810 [TBL] [Abstract][Full Text] [Related]
20. A plant-derived morphinan as a novel lead compound active against malaria liver stages. Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]